Back
BioNTech SE 10K Form
Sell
41
BNTX
BioNTech SE
Last Price:
99.31
Seasonality Move:
-2.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNTX News And Ratings
See the #1 stock for the next 7 days that we like better than BNTX
BNTX Financial Statistics
Sales & Book Value
| Annual Sales: | $18.26B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $88.46 |
| Price / Book: | 1.12 |
Profitability
| EPS (TTM): | 11.53840 |
|---|---|
| Net Income (TTM): | $2.84B |
| Gross Margin: | $13.48B |
| Return on Equity: | 14.21% |
| Return on Assets: | 11.96% |
BioNTech SE Earnings Forecast
Key BioNTech SE Financial Ratios
- The Gross Profit Margin over the past 6 years for BNTX is 73.82%.
- The Selling, General & Administrative Expenses for BNTX have been equal to 3.14% of Gross Profit Margin.
- The Research & Development expenses have been 134.16% of Revenue.
- The Interest Expense is 0.17% of Operating Income.
- The Net Earning history of BNTX is 54.50% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
BioNTech SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | BNTX |
| CUSIP: | 09075V |
| Website: | biontech.de |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 10.37 |
| Quick Ratio: | 9.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.5 |
|---|---|
| Forward P/E Ratio: | 36.57 |
BNTX Technical Analysis vs Fundamental Analysis
Sell
41
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy or a Sell?
-
BioNTech SE stock is rated a Sell
The current BioNTech SE [BNTX] share price is $99.40. The Score for BNTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.